INEOS Inovyn (Runcorn, U.K.) has completed the acquisition of the remaining 50% shareholding in Runcorn MCP Ltd. (Runcorn, U.K.), together with the assets and employees associated with ethylene dichloride (EDC) production at the Runcorn site from Vynova Runcorn Ltd. (Runcorn, U.K.), following the latter’s entry into administration in 2025.
The deal fully integrates the chlor-alkali and EDC value chain under INEOS Inovyn. By bringing these businesses together, INEOS Inovyn strengthens the long-term future of the site and its skilled workforce, while enhancing security of supply for customers.
Around 98% of the chlorine used in U.K. drinking water treatment is supplied by Runcorn, highlighting the site’s critical importance to public health and national infrastructure.
The acquisition represents an important step in safeguarding the continuity of strategically critical chlor-alkali operations in the U.K. These products are essential for safe drinking water and food manufacturing, and support a wide range of industries including pharmaceuticals, healthcare and construction. Strengthening the U.K.’s chlor-alkali industry is vital to the country’s strategic autonomy and national resilience.